MedPath

THERAPEUTIC EFFICACY OF DIFFERENT TYPES OF DRUGS IN ORAL SUBMUCOUS FIBROSIS IN SAURASHTRA REGION.

Not Applicable
Registration Number
CTRI/2022/02/040577
Lead Sponsor
Ashvin valaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Helthy individuals without any medically compromised condition accept oral submucous fibrosis

Exclusion Criteria

Medically compromise persons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in mouth openingTimepoint: 6 months of time
Secondary Outcome Measures
NameTimeMethod
Reduced burning sensation regain elasticity of mucosaTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath